Results 281 to 290 of about 710,185 (341)

When the immune system strikes twice: SLE-associated pulmonary arterial hypertension: a case report. [PDF]

Eur Heart J Case Rep
Carlier A, Smith V, De Pauw M, Vandecasteele E.   +3 more
europepmc   +1 more source

[Resistent arterial hypertension].

Terapevticheskii arkhiv, 2008
I E Chazova, V V Fomin
openaire   +2 more sources

Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals

Clinical Pharmacology &Therapeutics, EarlyView.
Data science approaches have been increasingly implemented in healthcare big data to evaluate the safety and effectiveness of drugs. Association discovery is a data mining approach that finds potentially associated elements in high‐dimensional data. We present a novel implementation of the association discovery approach in longitudinal healthcare data ...
George S. Q. Tan, Lynn Miller, Sam Wade, Jenni Ilomäki, Dickson Lukose, Jia Rong, Geoffrey I. Webb   +6 more
wiley   +1 more source

Protein biomarkers in pulmonary arterial hypertension: advances, clinical relevance, and translational challenges. [PDF]

J Transl Med
Niu Y, Tian J, Provencher S, Bonnet S, Boucherat O, Potus F, Gou D.   +6 more
europepmc   +1 more source

Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world edoxaban concentrations in older patients receiving reduced‐dose regimens. Low trough concentrations (< 12 ng/mL) were associated with an increased risk of thromboembolism. Among patients meeting the ELDERCARE‐AF criteria, low drug levels were more frequent with the 15 mg regimen than with the 30 mg regimen.
Sung‐Chun Tang, Shin‐Yi Lin, Chih‐Hao Chen, Yen‐Bin Liu, Li‐Ting Ho, Ching‐Hua Kuo, Yu‐Fong Peng, Chih‐Fen Huang, Jiann‐Shing Jeng   +8 more
wiley   +1 more source

Reimagining Arterial Hypertension and Dyslipidemia Care: Telemedicine's Promise and Pitfalls from the Slovak Patient Viewpoint. [PDF]

Clin Pract
Toth S, Jarolimkova A, Bucek P, Sevcik M, Fulop P, Poruban T.   +5 more
europepmc   +1 more source

Characterizing Alzheimer’s Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record–Based Data

Clinical Pharmacology &Therapeutics, EarlyView.
Hypertension is a known modifiable risk factor for Alzheimer’s disease and related dementia (ADRD). However, it is unknown how variance in hypertension control, antihypertensive medications, and social determinants of health, such as social deprivation index (SDI), influence the risk of developing ADRD.
Eissa A. Jafari, Mona Alshahawey, Muhammad A. Zaman, Steven M. Smith, Yan Gong, Glenn E. Smith, Caitrin W. McDonough   +6 more
wiley   +1 more source

Successful preoperative bridge with extracorporeal membrane oxygenation in three neonates with D-transposition of the great vessels and pulmonary hypertension [PDF]

, 2018
Gazit, Avihu Z, McBride, Mary E, Said, Ahmed S   +2 more
core   +1 more source

Safety of pericardiocentesis in pulmonary arterial hypertension: a systematic review. [PDF]

Front Cardiovasc Med
Cabada-Garcia MJ, Rodriguez-Rivera J, Jerjes-Sanchez C, Castillo-Perez M, Gutierrez-Gallegos P, Martinez-Rodriguez AL, Paredes-Gutierrez E, Quevedo-Salazar RC, De Leon-Gutierrez H, Lopez-Cortes OD, Panneflek J, Monjaras-Alvarado R, Moron-Mosso JA, Gonzalez-Medina JG.   +13 more
europepmc   +1 more source

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation

Clinical Pharmacology &Therapeutics, EarlyView.
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park, Jae‐Hwan Lee, Jin‐Ok Jeong, Diana A. Gorog, Udaya S. Tantry, Byeong‐Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Jin‐Yong Hwang, Young Bin Song, Sung Gyun Ahn, Jung‐Won Suh, Woong Gil Choi, Jung Rae Cho, Jeehoon Kang, Sang Yeub Lee, Hyo‐Soo Kim, Moo Hyun Kim, Do‐Sun Lim, Eun‐Seok Shin, Paul A. Gurbel, Young‐Hoon Jeong, on behalf of the PTRG‐DES Consortium Investigators   +22 more
wiley   +1 more source